Related Experiment Video
Updated: Dec 31, 2025

09:29
Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
Published on: October 29, 2015
30.7K
Correction to: Developing vaccines against epidemic-prone emerging infectious diseases
Valentina Bernasconi1, Paul A Kristiansen1, Mike Whelan2
1Coalition for Epidemic Preparedness Innovation (CEPI), Marcus Thranes gate 2, 0473, Oslo, Norway.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
|January 10, 2020
Summary
This article corrects an author name error. Richard Hatchett was incorrectly listed in the original publication.
Area of Science:
- Correction of publication errors
- Scientific authorship verification
Background:
- Ensuring accuracy in scientific literature is crucial.
- Proper attribution of research is a cornerstone of academic integrity.
Purpose of the Study:
- To rectify an error in author attribution.
- To ensure the correct identification of the author Richard Hatchett.
Main Methods:
- Review of the original publication.
- Implementation of a correction notice.
Main Results:
- The author's name has been corrected.
- The record now accurately reflects the author.
Conclusions:
- Accurate author attribution is essential for scientific record-keeping.
- Corrections ensure the integrity of published research.
Related Concept Videos
Vaccinations
51.0K
Overview
51.0K
Microorganisms in Medicine and Therapeutics
877
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
877
Steps in Outbreak Investigation
442
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
442
Cross-reactivity
32.7K
Overview
32.7K
Cancer Vaccines
894
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
894
Infection
11.5K
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
11.5K

